We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12 to 17 years
The JCVI is seeking evidence to inform possible changes to the HPV immunisation programme. We would like evidence around one-dose schedules for the HPV vaccine.
Statement from the Joint Committee on Vaccination and Immunisation on vaccinating children aged 5 to 11.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
The Joint Committee on Vaccination and Immunisation (JCVI) advises the UK government on vaccination and immunisation matters.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination for children aged 6 months to 4 years.
Statements setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the respiratory syncytial virus (RSV) immunisation programme.
Final statement from the Joint Committee on Vaccines and Immunisation (JCVI) on the groups that should be prioritised for vaccination in phase 2 of the programme.
Statement setting out the interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for 2023.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant.
An interim statement from the Joint Committee on Vaccination and Immunisation (JCVI) on pneumococcal vaccination for adults in the UK.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 booster vaccine programme for winter 2021 to 2022.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).